Vaccine increasingly likely by September this year

MELBOURNE: An injected vaccine against coronavirus could be ready by September.

A team of Oxford University immunology researchers are unusually optimistic about the chances of the vaccine — based on work already done on a chimpanzee-based vaccine and set to be trialled on humans in a fortnight.

Professor Sarah Gilbert, a no-nonsense scientist leading the study, said she was “80 per cent” confident of success.

“I think there’s a high chance that it will work based on other things that we have done with this type of vaccine,” she said.

“It’s not just a hunch and as every week goes by we have more data to look at … I would go for 80 per cent, that’s my personal view.”

The researchers began working on the vaccine on January 10.

So called “seed stock” of the vaccine is currently being produced at the University’s Clinical Biomanufacturing Facility.

From there, it will be transferred to Italian manufacturer Advent who will initially produce 1000 doses for the first clinical trials.

Researchers have recruited 510 healthy adults for the trial.